Broker Recommendations
Berenberg upgrades Hikma Pharmaceuticals to 'buy'
By Michele Maatouk
Date: Tuesday 03 Sep 2024
(Sharecast News) - Berenberg upgraded Hikma Pharmaceuticals on Tuesday and lifted the price target to 2,400p from 2,100p as it said "clear progress" had been made.
It said that after almost two years with a 'hold' rating, it believes the time is now right to upgrade the stock to a 'buy'.
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
Article Archive
You are here: news
